"With the exception of expanded access to already funded drugs, there has been no new investment in myeloma treatment since 2014," said Myeloma New Zealand.
New Zealand patients 'implore' PHARMAC to fund blood cancer therapy
September 16, 2022 Latest NewsBioPharma
Latest Video
New Stories
-
New survey reveals most see living with COVID-19 as the 'new normal'
June 9, 2023 - - Latest News -
Industry leaders join Biointelect's new executive strategy panel
June 9, 2023 - - Latest News -
NZ patients welcome biosimilar but disappointed at failure to expand access
June 9, 2023 - - Latest News -
BMS welcomes 'One-Stop Shop' for clinical trials as an important step
June 9, 2023 - - Latest News -
The 'Week in Review' Podcast - 9 June
June 8, 2023 - - Podcast -
AVITA Medical announces US approval of RECELL for full thickness skin defects
June 8, 2023 - - Australian Biotech -
New report reveals 'crippling' impact of double dispensed quantities
June 8, 2023 - - Latest News